Skip to main content
Equibles
SPRY logo

SPRY · ARS Pharmaceuticals, Inc. · Investor Relations

Track SPRY — free

Use SPRY with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SPRY.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$4.30 +0.01 (+0.12%)
Russell 2000 member Rebalance outlook locked
Market Cap
$405.75M
Shares
99.45M
Volume · Oct 6 1.22M Avg daily vol (3M) 1.85M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Past events

Date Event Type
2026-09-11 Cantor Fitzgerald Healthcare Conference Conference
2026-08-13 ARS Pharmaceuticals 2Q 2026 Financial Results Conference Call Earnings call
2026-05-15 Q1 FY2026 Earnings conference call (announced in 8-K) Earnings call
2026-03-09 Q4 Earnings conference call (announced in 8-K) Earnings call
2024-08-09 neffy® FDA Approval Call Event
2024-03-07 Neffy® Investor Day Presentation

Source: https://ir.ars-pharma.com/

Key facts CIK 1671858 CUSIP 82835W108 13F (30d) 5 filings 5 filers Visit website Investor relations